Inactive Instrument

SCHERING-PLOUGH Share Price

Equities

End-of-day quote Nyse Other stock markets
- ^USD	-

2009	SCHERING-PLOUGH : Schering profit rises	RE
2009	SCHERING-PLOUGH : profit beats views; cost cuts help	RE

SCHERING-PLOUGH : Schering profit rises	21/09/21	RE
SCHERING-PLOUGH : profit beats views; cost cuts help	21/09/21	RE
SCHERING-PLOUGH : Schering beats forecast, as Vytorin falls	21/08/21	RE

SCHERING-PLOUGH : Announces Sponsorship of Rabies-Control Projects in India	02/09/02	PR
SCHERING-PLOUGH : Investigational Sublingual Allergy Immunotherapy Tablet Meets Primary Endpoint in a Study of Adult Subjects With a History of Grass Pollen Allergies	02/09/02	PR
SCHERING-PLOUGH : U.S. Food and Drug Administration Issues Complete Response Letter Regarding PEGINTRON(R) for Malignant Melanoma	30/09/30	PR
SCHERING-PLOUGH : Standard & Poor's Announces Changes to U.S. Indices	30/09/30	PR
SCHERING-PLOUGH : Reports Financial Results for 2009 Third Quarter	22/09/22	PR

SCHERING-PLOUGH : troisième trimestre en ligne avec les attentes	22/09/22
Schering-Plough : BPA ajusté stable au 3e trimestre.	22/09/22
Schering-Plough : nouveaux essais sur un vaccin anti-grippe.	13/09/13
Schering-Plough : double approbation de la FDA pour Saphris.	14/09/14
Schering-Plough : accroît fortement ses résultats.	21/09/21

Sector

	1st Jan change	Capi.
CSL LIMITED	-3.79%	87.06B
SAMSUNG BIOLOGICS CO.,LTD.	+1.45%	40.25B
BIOGEN INC.	-15.94%	31.09B
UCB	+52.66%	24.74B
BIOMARIN PHARMACEUTICAL INC.	-14.50%	15.91B
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD.	-9.12%	11.96B
INCYTE CORPORATION	-14.38%	11.92B
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD.	-42.56%	11.61B
SWEDISH ORPHAN BIOVITRUM AB	+4.87%	8.73B